RFA
CARM

Reilly Financial Advisors’s Carisma Therapeutics CARM Stock Holding History

Reilly Financial Advisors’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2K Hold
100
– – ﹤0.01% 970
2021
Q3 		$2K Hold
100
– – ﹤0.01% 845
2021
Q2 		$9K Hold
100
– – ﹤0.01% 711
2021
Q1 		$5K Buy
100
+12
+14% +$566 ﹤0.01% 781
2020
Q4 		$2K Buy
88
+33
+60% +$837 ﹤0.01% 783
2020
Q3 		$2K Hold
55
– – ﹤0.01% 741
2020
Q2 		$1K Buy
55
+30
+120% +$405 ﹤0.01% 840
2020
Q1 		$0 Hold
25
– – ﹤0.01% 887
2019
Q4 		$1K Buy
25
+10
+67% +$230 ﹤0.01% 837
2019
Q3 		$0 Hold
15
– – ﹤0.01% 901
2019
Q2 		$0 Hold
15
– – ﹤0.01% 951
2019
Q1 		$0 Hold
15
– – ﹤0.01% 961
2018
Q4 		$0 Hold
15
– – ﹤0.01% 942
2018
Q3 		$1K Hold
15
– – ﹤0.01% 958
2018
Q2 		$1K Buy
+15
New +$661 ﹤0.01% 946
2017
Q1 		– Sell
-5
Closed – – 924
2016
Q4 		$0 Hold
5
– – ﹤0.01% 842
2016
Q3 		$0 Hold
5
– – ﹤0.01% 840
2016
Q2 		$0 Hold
5
– – ﹤0.01% 824
2016
Q1 		$0 Hold
5
– – ﹤0.01% 1204
2015
Q4 		$0 Hold
5
– – ﹤0.01% 1227
2015
Q3 		$0 Hold
5
– – ﹤0.01% 1306
2015
Q2 		$0 Buy
+5
New +$706 ﹤0.01% 1361

Other funds holding CARM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Reilly Financial Advisors's CARM Position: Q4 2021 in Review

Reilly Financial Advisors held its Carisma Therapeutics (CARM) position steady in Q4 2021 at 100 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #970.

Reilly Financial Advisors first reported a position in CARM in Q2 2015 and has held it in 22 quarters since. The position peaked at $9K in Q2 2021. 93 funds tracked by Wall St. Rank hold CARM as of Q4 2021.

  • Reilly Financial Advisors held 100 shares of Carisma Therapeutics worth $2K as of Q4 2021.
  • Reilly Financial Advisors left its Carisma Therapeutics share count unchanged in Q4 2021.
  • Carisma Therapeutics made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #970 holding.
  • Reilly Financial Advisors first reported a position in Carisma Therapeutics in Q2 2015 and has held it in 22 quarters since.
  • Reilly Financial Advisors's Carisma Therapeutics position peaked at $9K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.